tezosentan has been researched along with malondialdehyde in 1 studies
Studies (tezosentan) | Trials (tezosentan) | Recent Studies (post-2010) (tezosentan) | Studies (malondialdehyde) | Trials (malondialdehyde) | Recent Studies (post-2010) (malondialdehyde) |
---|---|---|---|---|---|
157 | 29 | 33 | 27,849 | 1,405 | 13,922 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ceylan, BG; Gulmen, S; Kiris, I; Mermi, B; Meteoglu, I; Narin, C; Sutcu, R | 1 |
1 other study(ies) available for tezosentan and malondialdehyde
Article | Year |
---|---|
Tezosentan reduces the renal injury induced by abdominal aortic ischemia-reperfusion in rats.
Topics: Acute Kidney Injury; Animals; Aorta, Abdominal; Aortic Diseases; Catalase; Endothelin Receptor Antagonists; Female; Kidney Glomerulus; Lipid Peroxidation; Male; Malondialdehyde; Necrosis; Oxidative Stress; Peroxidase; Postoperative Complications; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase; Tetrazoles; Vasodilator Agents | 2009 |